Physician

Kenneth R Pinna, M.D.

According to 2025 Medicare claims, Kenneth Pinna, M.D. (NPI: 1568423879) practices allergy/immunology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is SOUTHERN UTAH ALLERGY AND ASTHMA CLINIC PC (NPI: 1124163902; TIN: 200355426) and primary practice location at 84770-3931.

Pinna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 98,033 HCPCS/CPT codes, and received $1,780,308 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 2,224 prescription claims across 461 beneficiaries totaling $1,642,749 in drug costs, led by Haegarda (C1 Esterase Inhibitor). DME data shows 1,609 claims. Open Payments data shows 74 records totaling $3,808. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $164,413 to $1,780,308. Similarly, Part D prescription costs have moved sharply higher in recent years, from $239,540 to $1,642,749. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	420	19,676	$164,413
2016	456	22,581	$186,503
2017	472	21,716	$226,177
2018	528	24,507	$194,322
2019	506	20,431	$162,076
2020	505	19,708	$142,715
2021	462	15,942	$127,808
2022	498	18,997	$144,044
2023	505	18,748	$137,407
2024	516	98,033	$1,780,308

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	242	1,052	$239,540
2016	263	1,117	$207,740
2017	321	1,500	$199,946
2018	353	1,565	$285,695
2019	322	1,447	$287,890
2020	312	1,416	$396,300
2021	333	1,627	$810,111
2022	406	1,861	$594,287
2023	449	2,214	$1,634,004
2024	461	2,224	$1,642,749

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	144	1,259	$1,299,116
2016	189	1,381	$1,680,197
2017	200	1,723	$1,654,883
2018	177	1,835	$1,769,432
2019	172	2,074	$1,967,213
2020	199	2,037	$2,036,633
2021	148	1,887	$1,983,900
2022	149	1,670	$1,855,327
2023	123	1,528	$1,768,776
2024	146	1,609	$1,934,717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	183	183	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	324	511	$55
94010	Test to measure expiratory airflow and volume	169	270	$17
95165	Professional service for preparation and provision of 1 or more antigens	113	2,145	$9
95004	Test for allergy using allergenic extract	167	11,527	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Haegarda	C1 Esterase Inhibitor	13	364	$722,039
Firazyr	Icatibant Acetate	14	14	$357,803
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	206	7,680	$161,322
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	14	392	$96,081
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	79	2,730	$57,449

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	18	213	$677,851
J1555	Injection, immune globulin (cuvitru), 100 mg	N	15	139	$523,263
J1558	Injection, immune globulin (xembify), 100 mg	N	11	105	$356,591
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	40	$151,999
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	16	$76,127

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$3,808	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kenneth R. Pinna, M.D.?

Tedicare shows public-source Medicare data for Kenneth R. Pinna, M.D. (NPI 1568423879), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kenneth R. Pinna, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kenneth R. Pinna, M.D.?

Kenneth R. Pinna, M.D. is linked to SOUTHERN UTAH ALLERGY AND ASTHMA CLINIC PC (billing NPI 1124163902) in the available physician profile data.

Does Kenneth R. Pinna, M.D. have Open Payments data?

Kenneth R. Pinna, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.